COMISIÓN DE VIH E ITS

Efficacy and Safety of Switching to the 2-Drug Regimen Dolutegravir/Lamivudine Versus Continuing a 3- or 4-Drug Regimen for Maintaining Virologic Suppression in Adults Living With Human Immunodeficiency Virus 1 (HIV-1): Week 48 Results From the Phase

Detalles
Categoría de nivel principal o raíz: Bibliografía recomendada
COMISIÓN DE VIH E ITS
Autores: Llibre JM, Brites C, Cheng CY, Osiyemi O, van Wyk J et al
Revista: Clin Infect Dis. 2023 Feb 18;76(4):720-729.
DOI: https://doi.org/10.1093/cid/ciac130

Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV

Detalles
Categoría de nivel principal o raíz: Bibliografía recomendada
COMISIÓN DE VIH E ITS
Autores: Nadine Jaschinski, Lauren Greenberg, Bastian Neesgaard, Jose M Miró et al.; RESPOND Study Group
Revista: AIDS. 2023 Mar 1;37(3):467-475
DOI: https://doi.org/0.1097/QAD.0000000000003373

Mpox in people with advanced HIV infection: a global case series

Detalles
Categoría de nivel principal o raíz: Bibliografía recomendada
COMISIÓN DE VIH E ITS
Autores: Oriol Mitjà, Andrea Alemany, Michael Marks el al ; SHARE-NET writing group
Revista: Lancet. 2023 Mar 18;401(10380):939-949
DOI: https://doi.org/10.1016/S0140-6736(23)00273-8

First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic

Detalles
Categoría de nivel principal o raíz: Bibliografía recomendada
COMISIÓN DE VIH E ITS
Autores: Katerina A Christopoulos, Janet Grochowski, Francis Mayorga-Munoz, Monica Gandhi et al
Revista: Clin Infect Dis. 2023 Feb 8;76(3):e645-e651
DOI: https://doi.org/10.1093/cid/ciac631